Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2023 Earnings Call Transcript November 14, 2023 Taysha Gene Therapies, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13. Operator: Good afternoon and welcome to the Taysha Gene Therapies Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. […]
Taysha Gene Therapies, Inc (NASDAQ:TSHA) Receives $7 91 Consensus PT from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 9,930,000 shares, a growth of 34.9% from the August 31st total of 7,360,000 shares. Based on an average daily volume of 4,830,000 shares, the days-to-cover […]
Needham & Company LLC reiterated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a $5.00 target price on the stock. Several other research firms have also commented on TSHA. Robert W. Baird boosted their price […]
Taysha Gene Therapies (NASDAQ:TSHA) PT Lowered to $5 00 at Truist Financial theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.